Konstantinos Poulas, born in Athens in 1970, is an Associate Professor in the Department of Pharmacy at the University of Patras since 2003. He graduated from the Department of Biology at the University of Athens, where he also completed his Ph.D. With over 150 publications in international peer-reviewed journals, he has dedicated a significant part of his research career to understanding the structure and function of Nicotinic Acetylcholine Receptor(s) and its interaction with various ligands, autoantibodies, and monoclonal antibodies. Over the past ten years, his research has extensively expanded to the analysis of e-liquids (before and after vaping) and the investigation of vaping’s effects at the molecular, cellular, and histological levels. Concurrently, he has developed specialized and extensive research in the field of cannabinoids, exploring their properties and potential applications—a domain to which he is particularly dedicated and has made significant contributions through his publications.
He actively participates in national and European projects and has established an ISO-certified Vaping/Smoking lab in Patras, where extensive product testing is conducted for emissions and cellular toxicity. Beyond his academic role, Konstantinos Poulas serves as a Scientific Advisor to two Greek biotechnology companies. He is Chief Scientific Advisor at SITECPHARMA, focusing on the cultivation of medicinal cannabis and actively working on the biosynthesis of cannabinoids.
Share articles :